S. 4323: Ensuring Access to Lower-Cost Medicines for Seniors Act
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2026-04-16 |
| Sponsor | Sen. Lankford, James [R-OK] |
| Policy area | Health |
| Cosponsors | 1 |
| Latest action | 2026-04-16 — Read twice and referred to the Committee on Finance. |
| Last updated | 2026-05-18 |
Summary
Official summary (Introduced in Senate, 2026-04-16):
Ensuring Access to Lower-Cost Medicines for Seniors Act
This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.
Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.
Cosponsors (1)
| Name | Party / state |
|---|---|
| Margaret Wood Hassan | D NH (original cosponsor) 2026-04-16 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 4323 are published by Congress on congress.gov.
View S. 4323 on congress.gov →
Frequently asked questions
What is S. 4323?
S. 4323 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Ensuring Access to Lower-Cost Medicines for Seniors Act.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 4323 are available on congress.gov.
Bill data: congress.gov API (official congressional records).